Amanda L. Blackford - Concepedia

Author

Amanda L. Blackford

Also Known As

A Blackford, A. Blackford, A. L. Blackford, A.L. Blackford, Amanda Blackford, Amanda L Blackford, Amanda L. Blackford, Amanda Lapides Blackford, Blackford, Amanda, Elaine Bigelow

460

Publications

12.8K

Citations

H-Index

182

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medicine Cancer Research Center Harvard University

About

Amanda L. Blackford is an author at Johns Hopkins University specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	54	4.3K
2	Health Sciences	6	6	691
3	Engineering	2	2	268
4	Education	1	1	32
5	Management	1	1	15

Amanda L. Blackford

158

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts Simeon Springer, Yuxuan Wang, Marco Dal Molin, Gastroenterology Clinical Features ImprovePancreatic CancerMolecular MarkersPancreatic Fluid CollectionSurgical Pathology	2015	449
Egr-2 and Egr-3 are negative regulators of T cell activation M. Safford, Samuel L. Collins, Michael A. Lutz, Nature Immunology T Cell ActivationSignal TransductionCell RegulationT-regulatory CellImmunology	2005	439
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma Mark Sausen, Rebecca Leary, Siân Jones, Nature Genetics	2012	410
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance Marcia Irene Canto, Jose Alejandro Almario, Richard D. Schulick, Gastroenterology EpidemiologyPancreatic CancerCancer EpidemiologyCancer RiskPancreatic Fluid Collection	2018	382
<i>SMAD4</i> Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer Amanda L. Blackford, Oscar K. Serrano, Christopher L. Wolfgang, Clinical Cancer Research	2009	369
<i>RNAi</i> -Mediated Silencing of Nuclear Factor Erythroid-2–Related Factor 2 Gene Expression in Non–Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of Chemotherapy Anju Singh, Swetlana Boldin‐Adamsky, Rajesh K. Thimmulappa, Cancer Research	2008	366
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer Erica J. Childs, Evelina Mocci, Daniele Campa, Nature Genetics Pancreatic CancerMedicinePathologyCancer GenomicsCommon Variation	2015	265
PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer Steven P. Rowe, Katarzyna J. Macura, Esther Mena, Molecular Imaging and Biology Positron Emission TomographyMetastatic Prostate CancerUrologyImaging BiomarkersLesion Detection	2016	253
Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis Amanda L. Blackford, Marcia Irene Canto, Alison P. Klein, JNCI Journal of the National Cancer Institute Recent TrendsEpidemiology Of CancerPathologyPancreatic CancerOncology	2020	239
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma Steve Y. Cho, Evan J. Lipson, Hyung‐Jun Im, Journal of Nuclear Medicine	2017	234

Page 1